Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
As of close of business last night, IN8bio Inc’s stock clocked out at $0.18, down -5.97% from its previous closing price of $0.19. In other words, the price has decreased by $-5.97 from its previous closing price. On the day, 0.58 million shares were traded. INAB stock price reached its highest trading level at $0.19 during the session, while it also had its lowest trading level at $0.1726.
Ratios:
To gain a deeper understanding of INAB’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.08 and its Current Ratio is at 4.08. In the meantime, Its Debt-to-Equity ratio is 0.35 whereas as Long-Term Debt/Eq ratio is at 0.23.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Laidlaw on March 18, 2024, initiated with a Buy rating and assigned the stock a target price of $7.50.
On August 30, 2022, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $14.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INAB now has a Market Capitalization of 14464067 and an Enterprise Value of 8374060.
Stock Price History:
The Beta on a monthly basis for INAB is 0.19, which has changed by -0.8254902 over the last 52 weeks, in comparison to a change of 0.097913146 over the same period for the S&P500. Over the past 52 weeks, INAB has reached a high of $1.74, while it has fallen to a 52-week low of $0.13. The 50-Day Moving Average of the stock is -16.90%, while the 200-Day Moving Average is calculated to be -49.65%.
Shares Statistics:
It appears that INAB traded 5.25M shares on average per day over the past three months and 549180 shares per day over the past ten days. A total of 72.48M shares are outstanding, with a floating share count of 64.72M. Insiders hold about 20.35% of the company’s shares, while institutions hold 30.34% stake in the company. Shares short for INAB as of 1744675200 were 478257 with a Short Ratio of 0.09, compared to 1741910400 on 1668181. Therefore, it implies a Short% of Shares Outstanding of 478257 and a Short% of Float of 0.70999996.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The current rating of IN8bio Inc (INAB) is the result of assessments by 3.0 analysts actively engaged in evaluating its market dynamics.The consensus estimate for the next quarter is $-0.06, with high estimates of $-0.04 and low estimates of $-0.07.
Analysts are recommending an EPS of between $-0.17 and $-0.25 for the fiscal current year, implying an average EPS of $-0.21. EPS for the following year is $-0.23, with 5.0 analysts recommending between $-0.18 and $-0.28.
